Clinical Trials in Miami

Showing 8401-8420 of 8,701 trials

North American Study for the Treatment of Refractory Ascites (NASTRA)

NCT00006166

The NASTRA Clinical Trial is a multi-center, randomized, controlled clinical trial designed to determine if treatment with transjugular intrahepatic portasystemic shunts (TIPS) is superior to high volume paracentesis (total paracentesis, TP) for the treatment of refractory ascites due to cirrhosis. Only patients with clinically tense symptomatic ascites (shortness of breath, umbilical hernia, abdominal pain and/or distension, and/or limitation of activity) who have either diuretic-resistant ascites or diuretic-intractable ascites are being studied.

AscitesLiver Cirrhosis

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Started Mar 1997

Miami, Florida, United States • Omaha, Nebraska, United States • Portland, Oregon, United States +3 more locations

COMPLETEDPhase 4< 1 mile

Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation

NCT01046955

The purpose of this study is to observe in a randomized prospective study the effectiveness and toxicity of Thymoglobulin vs. Campath-1H used for induction therapy in recipients of living donor (LD) kidneys, compared with the investigators standard treatment protocol of Zenapax® and maintenance immunosuppression.

End-Stage Renal DiseaseLiving Donors

University of Miami38 participantsStarted Nov 2005

Miami, Florida, United States

UNKNOWNPhase 1< 1 mile

Safety and Efficacy Study of Intramuscular Uricase-PEG 20

NCT01038947

The purpose of this study is to assess the safety, pharmacokinetics and pharmacodynamics of single and multiple intramuscular doses of Uricase-PEG 20

GoutHyperuricemia

EnzymeRx28 participantsStarted Dec 2009

Miami, Florida, United States • Duncansville, Pennsylvania, United States

North American Study for the Treatment of Refractory Ascites (NASTRA)

Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation

Safety and Efficacy Study of Intramuscular Uricase-PEG 20

Find Trials by Condition in Miami

A Study to Evaluate the Pharmacokinetics of VI-0521 Subjects With Renal Impairment

A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment

Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

Memory Impairment Study (Mild Cognitive Impairment Study)

Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee

A Phase II Study Looking at Moderate to Severe Osteoarthritis Knee Pain

Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure

Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension

A Phase III Trial For Patients With Metastatic Breast Cancer

A Study Of Milnacipran In Patients With Fibromyalgia: Effects On 24 Hour Ambulatory Blood Pressure Monitoring

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation